US approves AstraZeneca, Daiichi's treatment for lung cancer

(Reuters) -AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat a type of lung cancer, marking the first approval of the therapy in this indication and expanding access for patients. Datroway has been approved in the United States, the world's biggest pharmaceuticals market, to treat an advanced form of non-small cell lung